Amplao, Anelyn .

HRN: 26-64-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2025
METRONIDAZOLE 500MG (TAB)
02/08/2025
02/14/2025
PO
1 Tab
TID
S/p NSVD; Thickly MSAF
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: